ArticleJournal of health economics and outcomes research2024

Cost-Minimization Analysis for Subcutaneous Daratumumab in the Treatment of Newly Diagnosed Multiple Myeloma in Three Gulf Countries.

Anas Hamad et al.PubMed ↗Full text ↗

No numbers read from the abstract.